Editorial
Antibiotic Susceptibility Surveillance of Environmental Legionella Strains: Application of the E-Test to Bacteria Isolated From Hospitals in Greece.
Ioanna G. Alexandropoulou1,2, Theodoros A. Parasidis1,2*, Theocharis G. Konstantinidis1,2, Theodoros C. Constantinidis3 and Maria Panopoulou1 |
||
1Microbiology Laboratory, Medical School, Democritus University of Thrace, Alexandropoulos, Greece | ||
2Regional Public Health Laboratory (East Macedonia-Thrace), Hellenic Centre for Disease Control and Prevention, Alexandropoulos, Greece | ||
3Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Alexandropoulos, Greece | ||
Corresponding Author : | Theodore A Parasidis Biologist, Microbiology Laboratory Medical School, Democritus University of Thrace Preclinical Courses Buildings, Campus, Medical school, Greece Tel/Fax: 302551075154 E-mail: tparasid@med.duth.gr |
|
Received December 01, 2013; Accepted December 03, 2013; Published December 10, 2013 | ||
Citation: Alexandropoulou IG, Parasidis TA, Konstantinidis TG, Constantinidis TC, Panopoulou M (2013) Antibiotic Susceptibility Surveillance of Environmental Legionella Strains: Application of the E-Test to Bacteria Isolated From Hospitals in Greece. J Infect Dis Ther 1:e103. doi: 10.4172/2332-0877.1000e103 | ||
Copyright: © 2013 Alexandropoulou IG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | ||
Related article at Pubmed Scholar Google |
Abstract
Legionella bacteria are the causative agent of legionellosis, an infection mainly acquired through aspiration of contaminated water. Macrolides and flouroquinolones are the treatment of choice for legionellosis. The selection of these categories is mainly based on clinical experience. Especially erythromycin was the first line drug in the treatment of legionellosis, even though erythomycin resistant strains can easily be obtained in vitro. Flouroquinolones has been shown to succeed high intracellular inhibition of Legionella compared with erythromycin